COPD Trial, Recruiting NCT06600126 Sponsor: University of Pennsylvania Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT06600126
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Patients:

  • People who are 18 years of age or older
  • People who have a confirmed COPD diagnosis, supported by breathing tests or imaging scans showing lung changes
  • People who score 8 or higher on a standard depression symptom questionnaire (called the PHQ-8) at the start of the study
  • People who can identify an adult caregiver to take part in the study alongside them
  • People who are able to join a phone or video call for around 30 minutes, up to once a week, for 12 sessions
  • People who speak Spanish and/or English

Caregivers:

  • People who are 18 years of age or older
  • People who are able to join a phone or video call for around 30 minutes, up to once a week, for 12 weeks

Who may not be able to join:

Patients:

  • People who have significant dementia or serious difficulties with memory and thinking
  • People whose COPD diagnosis has not yet been shared with them by their medical team, as recorded in their medical records
  • People who are currently receiving regular care from a licensed mental health professional
  • People who the trial team determines need to be urgently referred to specialist mental health care

Caregivers:

  • People who have significant dementia or serious difficulties with memory and thinking

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Joanna Hart, MD, MSHP, University of Pennsylvania

Phone: 267-271-0665

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
30 September 2024
Est. completion
1 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Patient Psychological Distress

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov